Missouri physician warns against injecting unapproved peptides sold online
MU Health Care's Regina DePietro says products such as BPC-157 lack the testing and post-market surveillance that approved drugs undergo.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 21 17:00 ETSource: St. Louis American
The wire
- 01DePietro warned consumers about peptides marketed on social media, cable and podcasts for muscle recovery and anti-aging, naming BPC-157 as unapproved.
- 02Some products are labeled for research purposes while being marketed to consumers, leaving ingredients, potency and side effects unverified.
- 03A separate Washington University iHeard STL survey of 179 adults in July 2026 found 91% had heard of GLP-1 drugs but only 30% believed they were safe.
From the source
Read at stlamerican.comUnapproved peptides raise health concerns
A University of Missouri physician is warning consumers about the potential dangers of injecting peptides that have not been approved by the Food and Drug Administration.
